Phase 3 clinical trial data showed average weight loss of 28.7% of body weight (approximately 71.2 pounds) at the 12 mg dose over 68 weeks
The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy
All other QoL measures including physical functioning, role functioning (physical or emotional), emotional well-being, social functioning, pain, and general health were not significantly altered by any supplementation (Table 3)
Over-the-Counter RX: Docusate Sodium: Stool softeners like docusate sodium (e.g., Colace) can help soften dry and hard stools, making them easier to pass
Why Medical Supervision Matters Responsible peptide use isnt something you should navigate alone
This is similar to what we see with other forms of significant weight loss, where changes in body composition can influence the menstrual cycle. I also asked if there are any gynecological issues that would prevent a doctor from prescribing a GLP-1 medication for weight loss